Local pharmacists said current tariff policies will make drugs more expensive and harder to find for consumers.

Pharmaceutical tariffs, as proposed by President Donald Trump, aim to create manufacturing jobs in the United States, limit ...

Celltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will remain largely unaffected ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Singapore is negotiating with the U.S. to ease tariffs on pharmaceuticals and secure access to advanced chips amid shifting ...

Global pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

China and the United States announced a truce in their trade war on Monday after talks in Geneva that will roll back the bulk ...

In short, the external world is moving faster than internal structures can keep up—and that’s a risk no company can afford.